Cargando…
Pharmaceutical Enterprises’ R&D Innovation Cooperation Moran Strategy When Considering Tax Incentives
Drug R&D innovation contributes to the high-quality development of the pharmaceutical industry, which is related to people’s life and health, economic development, and social stability. Tax incentives and industry cooperation are conducive to promoting pharmaceutical enterprises’ innovation. The...
Autores principales: | Xu, Yanping, Zhu, Lilong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9690677/ https://www.ncbi.nlm.nih.gov/pubmed/36429914 http://dx.doi.org/10.3390/ijerph192215197 |
Ejemplares similares
-
Pharmaceutical enterprises drug quality strategy Moran analysis considering government supervision and new media participation
por: Xu, Yanping, et al.
Publicado: (2023) -
Impact of incentive and selection strength on green technology innovation in Moran process
por: Zhang, Runtian, et al.
Publicado: (2020) -
Tax Incentives, Tax Enforcement, and Enterprise R&D Investment: Evidence From Chinese A-Share Listed
por: Sun, Ying
Publicado: (2022) -
Financial subsidies, tax incentives, and new energy vehicle enterprises’ innovation efficiency: Evidence from Chinese listed enterprises
por: Qian, Binhua
Publicado: (2023) -
Incentive effect of tax preferences towards the technological innovation of enterprises——Based on China’s GEM listed companies
por: Ding, Liang, et al.
Publicado: (2023)